You are here

Home > News > All Press Releases

Press Releases

Doubly Safe Activation

Doubly Safe Activation

26.03.2007
Molecular and Cell Biology, Immunology, Disease, Drugs & Diagnostics, Genetics
A team of Weizmann Institute scientists show that the immune system employs “dual key” activation to launch a potent antiviral weapon 'Dual key' activation, in which two people must act in concert to launch a weapon, is often installed to safeguard highly destructive arms. New research at the Weizmann Institute of Science shows that cells may employ this strategy as well before launching certain potent weapons of the immune system.  
One Membrane, Many Frequencies

One Membrane, Many Frequencies

26.03.2007
Brain & Behavior, Disease, Drugs & Diagnostics, Structural Biology
Scientists at the Weizmann Institute have discovered how a membrane in the inner ear may allow us to hear different frequencies Modern hearing aids, though quite sophisticated, still do not faithfully reproduce sound as hearing people hear it. New findings at the Weizmann Institute of Science shed light on a crucial mechanism for discerning different sound frequencies and thus may have implications for the design of better hearing aids.
It’s Only a Game of Chance

It’s Only a Game of Chance

26.03.2007
Brain & Behavior
A leading theory of perception has been called into question by a study at the Weizmann Institute of Science The validity of a leading theory that has held a glimmer of hope for unraveling the intricacies of the brain has just been called into question. Dr. Ilan Lampl of the Weizmann Institute of Science’s Neurobiology Department has produced convincing evidence to the contrary. His findings recently appeared in the journal Neuron.  
BioLineRx In-Licenses Two Additional Drug Candidates

BioLineRx In-Licenses Two Additional Drug Candidates

26.03.2007
Technology & Applications, Yeda Technology Transfer, Diagnostic Techniques and Drugs
Company expands therapeutic pipeline to fourteen by signing four in-licensing agreements in 2007    
Genes that slows cell division

Genes that slows cell division

25.02.2007
Space & Physics, Cancer, Molecular and Cell Biology, Disease, Drugs & Diagnostics, Genetics, Math & Computer Science
Weizmann Institute Scientists Discover: A Group of Genes that Slows Cell Division and Prevents Cancer  
Weizmann Institute scientists create: The First Molecular Keypad Lock

Weizmann Institute scientists create: The First Molecular Keypad Lock

23.01.2007
Disease, Drugs & Diagnostics, Organic Chemistry
Keypad locks, such as those for preventing auto theft, allow an action to take place only when the right password is entered: a series of numbers punched in a pre-set sequence. Now, a team of scientists at the Weizmann Institute of Science has created a molecule that can function as an ultra-miniaturized version of a keypad locking mechanism. Their work appeared in the Journal of the American Chemical Society (JACS).
Complex Channels

Complex Channels

23.01.2007
Biochemistry
Weizmann Institute scientists discover how ion channels are organized to effectively control nerve cell communication    
Genetic Risk Factor

Genetic Risk Factor

23.01.2007
Biochemistry, Cancer, Disease, Drugs & Diagnostics
Weizmann Institute scientists discover a genetic risk factor for smoking-linked head and neck cancer    
A new method developed at the Weizmann Institute of Science holds promise for treating brain injuries

A new method developed at the Weizmann Institute of Science holds promise for treating brain injuries

16.01.2007
Biochemistry, Brain & Behavior, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Diagnostic Techniques and Drugs
An injury to the brain can be devastating.  When brain cells die, whether from head trauma, stroke or disease, a substance called glutamate floods the surrounding areas, overloading the cells in its path and setting off a chain reaction that damages whole swathes of tissue. Glutamate is always present in the brain, where it carries nerve impulses across the gaps between cells. But when this chemical is released by damaged or dying brain cells, the result is a flood that overexcites nearby cells and kills them.  
A Transplant in Time

A Transplant in Time

26.12.2006
Immunology, Disease, Drugs & Diagnostics
Weizmann Institute Scientists demonstrate how tissues transplanted from pig embryos might, in the future, present a solution to genetic diseases  

Pages

 

Are you a journalist? Please sign up here for our press releases

 

Most Popular Articles

Let it Rain

Added particles in the atmosphere could be affecting rainfall patterns

Prof. Zvi Artstein, Vice President for Technology Transfer

Prof. Zvi Artstein

Israeli Researchers to Participate in European Commission Flagship

The European Commission has officially announced the selection of the Human Brain Project (HBP) as one of its two Future Emerging Technologies (FET) Flagship projects.